In the recent National Quality Survey (NSQ) report, the Central Drug Standards Control Organization (CDSCO) and various state units raised serious concerns about the quality of drugs on the market.
During the random sampling process in March, a total of 131 drugs were found to be of substandard quality. Shockingly, a sample collected from West Bengal was determined to be forged.
In response to these findings, the authorities have issued immediate instructions on the destruction of the entire affected batch and have taken strict action in accordance with regulatory norms. CDSCO urges consumers and stakeholders to remain alert and report any suspicious or low-quality medications.
This development highlights the urgent need to strengthen regulatory oversight and public awareness to ensure the safety and efficacy of drugs available to the public.
